Evidence map›Paper›PMID 37129723›Full record

ArticleJournal of medical systems2023

Automated Medical Diagnosis of Alzheimer´s Disease Using an Efficient Net Convolutional Neural Network.

Deevyankar Agarwal, Manuel Álvaro Berbís, Antonio Luna, Vivian Lipari, Julien Brito Ballester, Isabel de la Torre-Díez

Open access · hybridAbstract read
In one paragraph

Article in Journal of medical systems, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Identification of Eye Diseases Through Deep Learning.Diagnostics (Basel, Switzerland) · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Deevyankar AgarwalDepartment of Signal Theory and Communications and Telematics Engineering, University of Valladolid, Paseo de Belén 15, 47011, Valladolid, Spain. deevyankar.agarwal@estudiantes.uva.es.
Manuel Álvaro BerbísHospital San Juan de Dios, HT Médica, Avda Brillante 106, 14012, Córdoba, Spain.
Antonio LunaMRI Unit, Radiology Department, HT Médica, Carmelo Torres No. 2, 23007, Jaén, Spain.
Vivian LipariEuropean Atlantic University, Isabel Torres 21, 39011, Santander, Spain.
Julien Brito BallesterEuropean Atlantic University, Isabel Torres 21, 39011, Santander, Spain.
Isabel de la Torre-DíezDepartment of Signal Theory and Communications and Telematics Engineering, University of Valladolid, Paseo de Belén 15, 47011, Valladolid, Spain.
Universidad de Valladolid · ESUniversidad Europea del Atlántico · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease (AD) poses an enormous challenge to modern healthcare. Since 2017, researchers have been using deep learning (DL) models for the early detection of AD using neuroimaging biomarkers. In this paper, we implement the EfficietNet-b0 convolutional neural network (CNN) with a novel approach-"fusion of end-to-end and transfer learning"-to classify different stages of AD. 245 T1W MRI scans of cognitively normal (CN) subjects, 229 scans of AD subjects, and 229 scans of subjects with stable mild cognitive impairment (sMCI) were employed. Each scan was preprocessed using a standard pipeline. The proposed models were trained and evaluated using preprocessed scans. For the sMCI vs. AD classification task we obtained 95.29% accuracy and 95.35% area under the curve (AUC) for model training and 93.10% accuracy and 93.00% AUC for model testing. For the multiclass AD vs. CN vs. sMCI classification task we obtained 85.66% accuracy and 86% AUC for model training and 87.38% accuracy and 88.00% AUC for model testing. Based on our experimental results, we conclude that CNN-based DL models can be used to analyze complicated MRI scan features in clinical settings.

Indexed as

Alzheimer DiseaseCognitive DysfunctionEarly DiagnosisHumansMagnetic Resonance ImagingNeural Networks, ComputerNeuroimagingAlzheimer´s diseaseConvolutional neural networkDeep learningEfficientNetMild cognitive impairmentMONAIMRITransfer learning

Identifiers

PMID37129723
PMCPMC10154284
OpenAlexW4367668925

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.